✦ LIBER ✦

Concurrent daily chemotherapy with hyperfractionated thoracic irradiation in stage III NSCLC - Preliminary results of a pilot study

Book ID: 122940516
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 173 KB
Volume: 11
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(94)94460-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1100 Concurrent daily chemotherapy with

1100 Concurrent daily chemotherapy with hyperfractionated thoracic irradiation in stage IIIA & B NSCLC

✍ Lochrin, C.; Goss, G.; Cross, P.; Stewart, D.; Tomiak, E.; Agboola, O.; Aref, I. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 159 KB

P-593 Preliminary results of phase II st

P-593 Preliminary results of phase II study of daily paclitaxel andcarboplatin administered concurrently with chest irradiation in stage III unresectable NSCLC

✍ Wierzchowski, M.; Denisso, T.; Kowalski, D.; Lasota, W.; Zajda, K.; Krzakowski, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 139 KB

EP-1217 A PILOT STUDY OF CONTINUOUS ACCE

EP-1217 A PILOT STUDY OF CONTINUOUS ACCELERATED IRRADIATION IN PATIENTS WITH STAGE III NSCLC

✍ Galwas-Kliber, K.; Idasiak, A.; Blamek, S.; Suwinski, R. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Daily low-dose paclitaxel and concurrent

Daily low-dose paclitaxel and concurrent thoracic radiation in locally advanced NSCLC: Preliminary results of a radiobiology-based schedule in a phase I study

✍ Minatel, E; Franchin, G; Mascarin, M; Basso, B; Locatelli, A; Gigante, M; Muzzio 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Pilot study of accelerated hyperfraction

Pilot study of accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage III non-small cell lung carcinoma

✍ Jeffrey S. Brindle; Edward G. Shaw; John Q. Su; James A. Mailliard; Albert R. Fr 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 2 views

Daily (D) vs. twice-daily (BID) thoracic

Daily (D) vs. twice-daily (BID) thoracic irradiation (TI) with concurrent cisplatinietoposide (PE) chemotherapy as initial therapy for patients with limited small cell lung cancer (LSCLC): Preliminary results of a phase III prospective intergroup trial

✍ H. Wagner; K. Kim; D.H. Johnson; R. Komaki; W. Sause; W. Curran; R. Livingston; 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 144 KB